Clinical Trial Update: Treatment of Childhood Osteoporosis With Alendronate (Fosamax) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated alendronate (Fosamax) for treating osteoporosis in children and has completed, providing data on safety and preliminary efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Alendronate (Fosamax) (alendronate)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED